PATENT CLAIM ANALYSIS

Application Number: 16079588
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to a novel approach for treating inflammatory disorders and other diseases, which is based on targeting ROR gamma t mRNA. The invention is directed to oligonucleotides comprising 10 to 22 modified or unmodified nucleotides complementary to specifically selected regions of the RORC, transcript variant 2 mRNA (RORC2), which codes for the ROR gamma t protein.

Claim (Index 3):
The oligonucleotide of  claim 1 , wherein one or more linkages between the nucleotides are phosphorothioates.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 96.0
- Lexical Diversity: 1.32
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15882221', '14780043', '14779945', '14533371', '15593764']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7791302616932331
- 35 USC 102 Novelty (BERT): 0.509966928027945
- Combined Prediction Score: 0.7522139283267043
- Mean Citation Score: 271.251044
- Max Citation Score: 285.38016
- Similarity Product: 213.9631847816277

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test